These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38123738)

  • 1. Position statement of the German STI Society on the prophylactic use of doxycycline to prevent STIs (Doxy-PEP, Doxy-PrEP).
    Werner RN; Schmidt AJ; Potthoff A; Spornraft-Ragaller P; Brockmeyer NH;
    J Dtsch Dermatol Ges; 2024 Mar; 22(3):466-478. PubMed ID: 38123738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men.
    Cornelisse VJ; Riley B; Medland NA
    Med J Aust; 2024 Apr; 220(7):381-386. PubMed ID: 38479437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand - the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM).
    Cornelisse VJ; Ong JJ; Ryder N; Ooi C; Wong A; Kenchington P; Giola M; Donovan B; Dean JA; Molina JM; Medland NA
    Sex Health; 2023 Apr; 20(2):99-104. PubMed ID: 36927481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
    Luetkemeyer AF; Donnell D; Dombrowski JC; Cohen S; Grabow C; Brown CE; Malinski C; Perkins R; Nasser M; Lopez C; Vittinghoff E; Buchbinder SP; Scott H; Charlebois ED; Havlir DV; Soge OO; Celum C;
    N Engl J Med; 2023 Apr; 388(14):1296-1306. PubMed ID: 37018493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.
    Bachmann LH; Barbee LA; Chan P; Reno H; Workowski KA; Hoover K; Mermin J; Mena L
    MMWR Recomm Rep; 2024 Jun; 73(2):1-8. PubMed ID: 38833414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.
    Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM
    Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men.
    Wagner L; Boesecke C; Baumgarten A; Scholten S; Schellberg S; Hoffmann C; Audebert F; Noe S; Erber J; Lee M; Triebelhorn J; Schneider J; Spinner CD; Voit F
    Infection; 2024 Jul; ():. PubMed ID: 39042326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men.
    van Wees DA; Diexer S; Rozhnova G; Matser A; den Daas C; Heijne J; Kretzschmar M
    Sex Transm Infect; 2022 Sep; 98(6):395-400. PubMed ID: 34716228
    [No Abstract]   [Full Text] [Related]  

  • 10. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
    Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K;
    Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial Participants.
    Fredericksen RJ; Perkins R; Brown CE; Cannon C; Lopez C; Cohee A; Dombrowski JC; Cohen S; Malinski C; Powell M; Luetkemeyer AF; Celum C; Christopoulos K
    AIDS Patient Care STDS; 2024 Apr; 38(4):155-167. PubMed ID: 38656217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and Solutions to STI Control in the Era of HIV and STI Prophylaxis.
    Mogaka FO; Stewart J; Omollo V; Bukusi E
    Curr HIV/AIDS Rep; 2023 Oct; 20(5):312-319. PubMed ID: 37751130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis.
    Zeggagh J; Bauer R; Delaugerre C; Carette D; Fressard L; Charreau I; Chidiac C; Pialoux G; Tremblay C; Cua E; Robineau O; Raffi F; Capitant C; Spire B; Meyer L; Molina JM;
    AIDS; 2022 Jul; 36(8):1129-1134. PubMed ID: 35142708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.
    Kiefer EM; Ross KS; Santos AC; Barney MR; McCormick TJ; Chow DC; Shikuma CM
    Hawaii J Health Soc Welf; 2021 Jul; 80(7):148-154. PubMed ID: 34278321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexually Transmitted Infection Screening Among Gay, Bisexual, and Other Men Who Have Sex With Men Prescribed Pre-exposure Prophylaxis in Baltimore City, Maryland.
    Schumacher C; Wu L; Chandran A; Fields E; Price A; Greenbaum A; Jennings JM;
    Clin Infect Dis; 2020 Dec; 71(10):2637-2644. PubMed ID: 31761944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
    Hovaguimian F; Kouyos RD; Kusejko K; Schmidt AJ; Tarr PE; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Darling KEA; Depmeier C; Läuchli S; Reinacher M; Rasi M; Nicca D; Bruggmann P; Haerry D; Bize R; Low N; Vock F; El Amari EB; Böni J; Bosshard PP; Fehr JS; Hampel B;
    HIV Med; 2024 Jan; 25(1):117-128. PubMed ID: 37771207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022.
    von Schreeb S; Pedersen SK; Christensen H; Jørgsensen KM; Harritshøj LH; Hertz FB; Ahlström MG; Lebech AM; Lunding S; Nielsen LN; Gerstoft J; Kronborg G; Engsig FN
    Euro Surveill; 2024 Mar; 29(13):. PubMed ID: 38551099
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.